In summary, the identification and characterization of the link among TDO, Kyn and AhR, including its negative feedback mechanisms,66 may pave the way for targeted therapeutic interventions to allow abrogation of HCV immune evasion mechanisms and bystander suppression of anti-HCC immune responses. The gene discussed is AHR; the disease is hepatocellular carcinoma.